The Therapeutic Vaccine: Is it Feasible?
Authors:
- Lutz GissmannLGLutz Gissmann
- Karen NietoKNKaren Nieto
- 1 August 2009
- journal article
- review article
- Published by Elsevier in Archives of Medical Research
- Vol. 40 (6) , 493-498
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Arrangement of L2 within the Papillomavirus CapsidJournal of Virology, 2008
- Recent advances in strategies for immunotherapy of human papillomavirus‐induced lesionsInternational Journal of Cancer, 2007
- The E5 protein of the human papillomavirus type 16 down-regulates HLA-I surface expression in calnexin-expressing but not in calnexin-deficient cellsVirology Journal, 2007
- Integration of the HPV16 genome does not invariably result in high levels of viral oncogene transcriptsOncogene, 2007
- Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trialsCanadian Medical Association Journal, 2007
- Vaccination trial with HPV16 L1E7 chimeric virus‐like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3)International Journal of Cancer, 2007
- Enhancement of vaccinia vaccine potency by linkage of tumor antigen gene to gene encoding calreticulinVaccine, 2004
- Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patientsJournal of Cancer Research and Clinical Oncology, 2003
- Control of interferon signaling in human papillomavirus infectionCytokine & Growth Factor Reviews, 2001
- HPV16 L1E7 chimeric virus-like particles induce specific HLA-restricted T cells in humans afterin vitro vaccinationInternational Journal of Cancer, 2001